Carbimazole
- Generic Name
- Carbimazole
- Drug Type
- Small Molecule
- Chemical Formula
- C7H10N2O2S
- CAS Number
- 22232-54-8
- Unique Ingredient Identifier
- 8KQ660G60G
Overview
An imidazole antithyroid agent. Carbimazole is metabolized to methimazole, which is responsible for the antithyroid activity.
Background
An imidazole antithyroid agent. Carbimazole is metabolized to methimazole, which is responsible for the antithyroid activity.
Indication
For the treatment of hyperthyroidism and thyrotoxicosis. It is also used to prepare patients for thyroidectomy.
Associated Conditions
- Hyperthyroidism
Clinical Trials
FDA Approved Products
No FDA products found for this drug
Singapore Approved Products
CARBIMAZOLE 5 TABLET 5 mg
Manufacturer:REMEDICA LTD
Form:TABLET, FILM COATED
Strength:5 mg
Online:Yes
Approved: 1992/03/23
Approval:SIN06923P
CARBIMAZOLE TABLET 5 mg
Manufacturer:SUNWARD PHARMACEUTICAL PRIVATE LIMITED
Form:TABLET
Strength:5 mg
Online:Yes
Approved: 1990/05/22
Approval:SIN04453P
CAMAZOL TABLET 5 mg
Manufacturer:XEPA-SOUL PATTINSON (MALAYSIA) SDN BHD
Form:TABLET
Strength:5 mg
Online:Yes
Approved: 1990/05/22
Approval:SIN04490P
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath